ECCTR enters second phase

ECCTR registry will collect and collate data on availability of corneal tissue, methods of transplantation and visual outcomes

ECCTR enters second phase
Colin Kerr
Colin Kerr
Published: Wednesday, November 1, 2017
[caption id="attachment_10140" align="alignleft" width="1024"] Dr Mats Lundström[/caption] One of the highlights of the 8th EuCornea Congress was an instructional course that explained how and why cornea specialists should get involved with the European Cornea and Cell Transplantation Registry (ECCTR), a registry system for corneal surgeons co-funded by the ESCRS. “This course provided a thorough introduction to the ECCTR system and included discussion of the project’s legal and ethical aspects, as well as detailed instructions on how to report and take out data, and how to use your own data in order to improve your practice,” said Dr Mats Lundström, Sweden, who together with Mor Dickman MD, the Netherlands, presented the course. The ECCTR registry will collect and collate data on availability of corneal tissue, methods of transplantation, and visual outcomes, said Dr Lundström. He and the registry team have so far harmonised three existing national European corneal registries, in the Netherlands, Sweden and the UK, and will soon be recruiting individual surgeons and centres of excellence to participate in the project. “We are hoping that this registry will be a valuable tool for benchmarking and comparison. We know that when it comes to a specific type of surgery the best way to perform surgery isn’t always found within your own region or even within your own country. It’s definitely an advantage to have a broader international field of data for comparison,” Dr Lundström said. ENTERING THE RECRUITMENT PHASE The ECCTR had its official launch at the XXXIV ESCRS Congress in Copenhagen. The project is a three-year programme, with the now completed development of an EU web registry in the first year, followed by recruitment of clinics and eye banks and the collection of data starting in the second year. At the 9th EUCORNEA Congress in 2018, the ECCTR’s leading investigators will present their data and will also use the data for creating European guidelines for corneal transplant surgery. The instructional course in Lisbon represents the initiation of the second, recruitment stage of the project, said Dr Lundström. “We have actually built the software and it has been tested by representatives for the three involved national registers and for the steering group. After a number of updates, we are now in the phase that a few clinics will test how it works as a sort of a beta version in a test database.” The project is co-funded by the ESCRS and by the EU under the Consumers, Health, Agriculture and Food Executive Agency (CHAFEA).
Tags: European Cornea and Cell Transplantation Registry (ECCTR)
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...